vs

Side-by-side financial comparison of BLUE RIDGE BANKSHARES, INC. (BRBS) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $20.8M, roughly 1.6× BLUE RIDGE BANKSHARES, INC.). BLUE RIDGE BANKSHARES, INC. runs the higher net margin — 20.4% vs -28.1%, a 48.5% gap on every dollar of revenue. On growth, BLUE RIDGE BANKSHARES, INC. posted the faster year-over-year revenue change (-5.2% vs -18.9%). BLUE RIDGE BANKSHARES, INC. produced more free cash flow last quarter ($11.9M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs -14.0%).

Blue Ridge Bankshares, Inc. is a U.S.-based financial holding company operating through its banking subsidiary. It offers retail and commercial banking services including deposit accounts, loans, and wealth management solutions, serving individual consumers and small to mid-sized businesses across Virginia and North Carolina.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

BRBS vs RXST — Head-to-Head

Bigger by revenue
RXST
RXST
1.6× larger
RXST
$32.6M
$20.8M
BRBS
Growing faster (revenue YoY)
BRBS
BRBS
+13.7% gap
BRBS
-5.2%
-18.9%
RXST
Higher net margin
BRBS
BRBS
48.5% more per $
BRBS
20.4%
-28.1%
RXST
More free cash flow
BRBS
BRBS
$14.2M more FCF
BRBS
$11.9M
$-2.3M
RXST
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
-14.0%
BRBS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BRBS
BRBS
RXST
RXST
Revenue
$20.8M
$32.6M
Net Profit
$4.2M
$-9.2M
Gross Margin
77.5%
Operating Margin
25.9%
-34.8%
Net Margin
20.4%
-28.1%
Revenue YoY
-5.2%
-18.9%
Net Profit YoY
311.9%
-54.1%
EPS (diluted)
$0.05
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRBS
BRBS
RXST
RXST
Q4 25
$20.8M
$32.6M
Q3 25
$25.7M
$30.3M
Q2 25
$23.1M
$33.6M
Q1 25
$22.1M
$37.9M
Q4 24
$21.9M
$40.2M
Q3 24
$21.8M
$35.3M
Q2 24
$20.4M
$34.9M
Q1 24
$28.1M
$29.5M
Net Profit
BRBS
BRBS
RXST
RXST
Q4 25
$4.2M
$-9.2M
Q3 25
$5.6M
$-9.8M
Q2 25
$1.3M
$-11.8M
Q1 25
$-434.0K
$-8.2M
Q4 24
$-2.0M
$-5.9M
Q3 24
$946.0K
$-6.3M
Q2 24
$-11.4M
$-6.1M
Q1 24
$-2.9M
$-9.1M
Gross Margin
BRBS
BRBS
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
BRBS
BRBS
RXST
RXST
Q4 25
25.9%
-34.8%
Q3 25
29.1%
-40.1%
Q2 25
7.7%
-41.6%
Q1 25
-4.0%
-28.2%
Q4 24
-14.1%
-21.5%
Q3 24
7.1%
-26.1%
Q2 24
-59.2%
-23.9%
Q1 24
-11.7%
-36.2%
Net Margin
BRBS
BRBS
RXST
RXST
Q4 25
20.4%
-28.1%
Q3 25
21.8%
-32.4%
Q2 25
5.6%
-35.0%
Q1 25
-2.0%
-21.6%
Q4 24
-10.5%
-14.8%
Q3 24
4.3%
-17.9%
Q2 24
-56.2%
-17.4%
Q1 24
-10.3%
-30.8%
EPS (diluted)
BRBS
BRBS
RXST
RXST
Q4 25
$0.05
$-0.22
Q3 25
$0.06
$-0.24
Q2 25
$0.01
$-0.29
Q1 25
$-0.01
$-0.20
Q4 24
$0.30
$-0.14
Q3 24
$0.01
$-0.16
Q2 24
$-0.47
$-0.16
Q1 24
$-0.15
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRBS
BRBS
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$228.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$323.7M
$275.7M
Total Assets
$2.4B
$311.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRBS
BRBS
RXST
RXST
Q4 25
$228.1M
Q3 25
$227.5M
Q2 25
$227.5M
Q1 25
$229.3M
Q4 24
$237.2M
Q3 24
$237.1M
Q2 24
$233.3M
Q1 24
$125.4M
Stockholders' Equity
BRBS
BRBS
RXST
RXST
Q4 25
$323.7M
$275.7M
Q3 25
$355.5M
$276.0M
Q2 25
$344.3M
$278.0M
Q1 25
$338.3M
$279.3M
Q4 24
$327.8M
$281.2M
Q3 24
$336.3M
$277.3M
Q2 24
$325.6M
$275.2M
Q1 24
$180.9M
$163.9M
Total Assets
BRBS
BRBS
RXST
RXST
Q4 25
$2.4B
$311.8M
Q3 25
$2.5B
$308.5M
Q2 25
$2.6B
$309.0M
Q1 25
$2.7B
$313.0M
Q4 24
$2.7B
$318.6M
Q3 24
$2.9B
$310.5M
Q2 24
$2.9B
$305.5M
Q1 24
$3.1B
$183.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRBS
BRBS
RXST
RXST
Operating Cash FlowLast quarter
$13.6M
$-1.1M
Free Cash FlowOCF − Capex
$11.9M
$-2.3M
FCF MarginFCF / Revenue
57.4%
-6.9%
Capex IntensityCapex / Revenue
8.1%
3.5%
Cash ConversionOCF / Net Profit
3.21×
TTM Free Cash FlowTrailing 4 quarters
$24.6M
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRBS
BRBS
RXST
RXST
Q4 25
$13.6M
$-1.1M
Q3 25
$6.4M
$-1.2M
Q2 25
$10.7M
$-4.4M
Q1 25
$-3.6M
$-8.8M
Q4 24
$-6.3M
$-4.3M
Q3 24
$24.1M
$650.0K
Q2 24
$-4.8M
$-4.0M
Q1 24
$-7.5M
$-9.3M
Free Cash Flow
BRBS
BRBS
RXST
RXST
Q4 25
$11.9M
$-2.3M
Q3 25
$5.7M
$-1.8M
Q2 25
$10.5M
$-5.9M
Q1 25
$-3.6M
$-9.4M
Q4 24
$-6.9M
$-5.1M
Q3 24
$23.9M
$-453.0K
Q2 24
$-5.0M
$-5.5M
Q1 24
$-7.6M
$-11.3M
FCF Margin
BRBS
BRBS
RXST
RXST
Q4 25
57.4%
-6.9%
Q3 25
22.3%
-5.8%
Q2 25
45.6%
-17.6%
Q1 25
-16.4%
-24.8%
Q4 24
-31.4%
-12.7%
Q3 24
109.6%
-1.3%
Q2 24
-24.4%
-15.9%
Q1 24
-26.9%
-38.2%
Capex Intensity
BRBS
BRBS
RXST
RXST
Q4 25
8.1%
3.5%
Q3 25
2.7%
1.9%
Q2 25
0.6%
4.6%
Q1 25
0.1%
1.5%
Q4 24
2.7%
2.1%
Q3 24
1.1%
3.1%
Q2 24
0.8%
4.4%
Q1 24
0.2%
6.7%
Cash Conversion
BRBS
BRBS
RXST
RXST
Q4 25
3.21×
Q3 25
1.15×
Q2 25
8.22×
Q1 25
Q4 24
Q3 24
25.51×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BRBS
BRBS

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons